SUVmax sheds light on prognosis for patients with NSCLC

02/9/2013 | AuntMinnie.com (free registration)

Maximum standardized uptake value as measured by PET/CT may help improve prediction of progression-free survival in patients with early-stage non-small cell lung cancer undergoing stereotactic body radiation therapy, according to findings presented at an imaging and radiation therapy conference. The study involved patients who had PET/CT imaging with SUVmax assessment before undergoing treatment. SUVmax assessment may allow for more tailored treatment strategies and ultimately better outcomes, a researcher said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ